 Correlation antibodies II collagen treatment outcome bilateral progressive sensorineural hearing loss aim idiopathic bilateral progressive sensorineural hearing loss BPSHL immunological cause patients antibodies type II collagen ELISA eighteen patients BPSHL corticosteroid treatment twelve patients Meniere disease fifteen otosclerosis eighteen rheumatoid arthritis fibrositis healthy controls positive result mean dilution titre eighteen BPSHL patients positive titres group Meniere disease otosclerosis others mean antibody titre BPSHL group group SEM vs Meniere disease otosclerosis others BPSHL patients clinical response corticosteroids improvement tone audiogram db speech discrimination score mean antibody titre vs non-responsive patients patients BPSHL immunity II collagen major constituent inner ear important pathogenesis disorder